Shanghai, China

Wujie Cao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shanghai Zhonghua Pharmaceutical Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wujie Cao. Retrieved from https://idiyas.com/inventor/wujie-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wujie Cao: Innovator in Medicinal Applications

Introduction

Wujie Cao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the area of liver health. His innovative work has led to the development of a unique medicament aimed at preventing and treating liver fibrosis.

Latest Patents

Wujie Cao holds a patent for the "Application of Longhu Rendan in preparing medicament for preventing and/or treating liver fibrosis." This patent highlights the effectiveness of Longhu Rendan in improving fibrosis. The medicament demonstrates an anti-liver fibrosis effect and liver protection that is comparable to the positive drug silybin. This advancement is crucial for patients suffering from liver-related ailments.

Career Highlights

Cao is associated with Shanghai Zhonghua Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving health outcomes through scientific research and development.

Collaborations

Wujie Cao collaborates with esteemed colleagues, including Jiahua Jin and Biye Wang. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Wujie Cao's contributions to medicinal applications, particularly in liver health, underscore his role as an influential inventor. His patent on Longhu Rendan represents a significant step forward in the treatment of liver fibrosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…